King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. An S&P 500 Index company, King seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and life-cycle management.

Contact Information

501 Fifth Street
Bristol, TN 37620

tel: 423-989-8000
fax: 423-274-8677


Investor Relations



Exchange: NYSE
Industry: Drug Manufacturers - Other
Market Cap: $2.4B

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.